$3250 | Single User
$4650 | Site License
$5650 | Global License

Irritable Bowel Syndrome (IBS) Treatment Market, By Type (Viberzi, Amitiza, Xifaxan, Linzess/Constella), By Product, and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jun 2020 | 270620 | In Stock
Related Topics: Agencies , AstraZeneca , Iron , Pharmaceuticals

Introduction

REPORT HIGHLIGHT

Irritable Bowel Syndrome (IBS) treatment market was valued at USD XX billion by 2019, growing with XX% CAGR during the forecast period, 2020-2026

Market Dynamics

Irritable bowel syndrome (IBS) is an illness of gastrointestinal tract (GT) with symptoms such as severe abdominal pain and alteration of bowel habits. Generally, the movement of food is because of the intestinal contraction and the digested food is passed through the GT. The irritable bowel syndrome hampers natural movements of that muscle, by which the food material is not able to pass through the digestive tract and ultimately results in severe abdominal pain, cramping, diarrhoea, constipation, mucus in the stool, and bloating & gas. The Centers for Disease Control (CDC) and Prevention in 2015 had reported that around 3 million people in the U.S. were testified being treated with irritable bowel syndrome. This syndrome can be treated by proper medication, making favourable changes in the daily diet, and by reducing stress.

Growing prevalence of gastrointestinal diseases, increasing adoption of a sedentary lifestyle, and consumption of unhealthy diet are the major factors driving the growth of global irritable bowel syndrome treatment market. In addition, rising geriatric population and increased level of stress among individuals are other factors propelling the market growth.

Irritable bowel syndrome is considered as one of the most common gastrointestinal functional disorders, which has an estimated global incidence rate of 10-15%. Of all the patient visits to gastroenterologists, approx. 25-45% are due to symptoms of irritable bowel syndrome. Yet many people remain undiagnosed and unaware that their symptoms show a disorder that is medically recognized. Thus, the increase in awareness programs for the treatment of IBS, and launches of numerous developed pipeline drugs for the treatment are likely to create massive growth opportunities in the market. However, high competition amongst major industry players and lack of specific treatment are expected to restrict the market growth in the coming future.

Types Takeaway

Based on type, the diarrhoea-predominant (IBS-D) segment subjugated the IBS treatment market in 2018 owing to rising prevalence of gastrointestinal disorders and diseases such as increased stress levels, abdominal pain, and alteration of bowel habit. The constipation-predominant (IBS-C) segment is expected to grow at the fastest rate during the forecast period owing to the presence of promising products such as Tenapanor and SYN-010.

Linaclotide or linzess/constella is hugely adopted product in the major regions of the U.S., Germany, U.K., Japan, Italy, and Spain. In 2018, the lizness product experienced a substantial growth rate in Japan. Because of these factors, the lizness/constella product segment is estimated to dominate the market in terms of revenue by the end of 2030. Linaclotide is marketed by Allergan and Ironwood in the U.S. as Linzess. And Allergan markets the linaclotide in Europe under the brand name Constella. In China and Japan, AstraZeneca and Astellas have the exclusive rights to market and develop linaclotide as Linzess respectively.

Regional Takeaway

Presently, the North America region is predicted to continue its trend in the irritable bowel syndrome treatment market. This region is projected to register the majority of shares owing to the huge availability of medical professionals, the presence of major market players, well-established healthcare infrastructure, and rising gastrointestinal diseases. On the other hand, Asia-Pacific is estimated to be the second-largest market followed by Europe and LAMEA. High population base, rising awareness of patients, and an increase in geriatric population will boost the growth of Asia Pacific IBS treatment market.

Key Vendors Takeaway

The major players functioning in the global market are applying several strategies such as mergers & acquisitions and product launches to increase their market share. Some of the prominent players include:

• Ironwood Pharmaceuticals, Inc.

• Astellas Pharma, Inc.

• Allergan

• Takeda Pharmaceutical Company Limited

• Sebela Pharmaceuticals Inc.

• AstraZeneca

• Synergy Pharmaceuticals Inc.

• Synthetic Biologics, Inc.

• Bausch Health

• Ardelyx

The market size and forecast for each segment and sub-segments has been considered as below:

• Historical Year – 2015 to 2018

• Base Year – 2019

• Estimated Year – 2020

• Projected Year – 2026

TARGET AUDIENCE

 Traders, Distributors, and Suppliers

 Manufacturers

 Government and Regional Agencies

 Research Organizations

 Consultants

 Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY TYPES

 IBS-D

o Viberzi

o Xifaxan

o Others

 IBS-C

o Amitiza

o Linzess/Constella

o Others

GLOBAL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY PRODUCT

 Viberzi

 Linzess/Constella

 Xifaxan

 Amitiza

 Others

GLOBAL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY REGION

 North America

o The U.S.

o Canada

 Europe

o Germany

o France

o Italy

o Spain

o United Kingdom

o Rest of Europe

 Asia Pacific

o India

o China

o South Korea

o Japan

o Singapore

o Rest of APAC

 Latin America

o Brazil

o Mexico

o Argentina

o Rest of LATAM

 Middle East and Africa

o Saudi Arabia

o United Arab Emirates

o Rest of MEA

Table of Contents
for Irritable Bowel Syndrome (IBS) Treatment Market, By Type (Viberzi, Amitiza, Xifaxan, Linzess/Constella), By Product, and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

  • TABLE OF CONTENT

    1. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Market Snippet

    2.1.1. Market Snippet by Types

    2.1.2. Market Snippet by Product

    2.1.3. Market Snippet by Application

    2.1.4. Market Snippet by Region

    2.2. Competitive Insights

    3. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT INDUSTRY STUDY

    4.1. Porter’s Five Forces Analysis

    4.2. Marketing Strategy Analysis

    4.3. Growth Prospect Mapping

    4.4. Regulatory Framework Analysis

    4.5. COVID-19 Impact Analysis

    4.5.1. Pre-COVID-19 Impact Analysis

    4.5.2. Post-COVID-19 Impact Analysis

    5. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    5.3. Breakdown Data, by Key manufacturer

    5.3.1. Established Player Analysis

    5.3.2. Emerging Player Analysis

    6. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET – BY TYPES

    6.1. Overview

    6.1.1. Segment Share Analysis, By Types, 2019 & 2026 (%)

    6.2. IBS-D

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.3. Viberzi

    6.2.3.1. Overview

    6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.4. Xifaxan

    6.2.4.1. Overview

    6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.2.5. Others

    6.2.5.1. Overview

    6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3. IBS-C

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.3. Amitiza

    6.3.3.1. Overview

    6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.4. Linzess/Constella

    6.3.4.1. Overview

    6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3.5. Others

    6.3.5.1. Overview

    6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET – BY PRODUCT

    7.1. Overview

    7.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)

    7.2. Viberzi

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.3. Linzess/Constella

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.4. Xifaxan

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.5. Amitiza

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.6. Others

    7.6.1. Overview

    7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)

    8.2. North America

    8.2.1. Overview

    8.2.2. Key Manufacturers in North America

    8.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.2.4. North America Market Size and Forecast, By Types, 2015 - 2026 (US$ Million)

    8.2.5. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    8.2.6. U.S.

    8.2.6.1. Overview

    8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.2.7. Canada

    8.2.7.1. Overview

    8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Key Manufacturers in Europe

    8.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.3.4. Europe Market Size and Forecast, By Types, 2015 - 2026 (US$ Million)

    8.3.5. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    8.3.6. Germany

    8.3.6.1. Overview

    8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.7. Italy

    8.3.7.1. Overview

    8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.8. United Kingdom

    8.3.8.1. Overview

    8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.9. France

    8.3.9.1. Overview

    8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3.10. Rest of Europe

    8.3.10.1. Overview

    8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Key Manufacturers in Asia Pacific

    8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.4.4. Asia Pacific Market Size and Forecast, By Types, 2015 - 2026 (US$ Million)

    8.4.5. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    8.4.6. India

    8.4.6.1. Overview

    8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.7. China

    8.4.7.1. Overview

    8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.8. Japan

    8.4.8.1. Overview

    8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.9. South Korea

    8.4.9.1. Overview

    8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4.10. Rest of APAC

    8.4.10.1. Overview

    8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5. Latin America

    8.5.1. Overview

    8.5.2. Key Manufacturers in Latin America

    8.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.5.4. Latin America Market Size and Forecast, By Types, 2015 - 2026 (US$ Million)

    8.5.5. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    8.5.6. Brazil

    8.5.6.1. Overview

    8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.7. Mexico

    8.5.7.1. Overview

    8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.8. Argentina

    8.5.8.1. Overview

    8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5.9. Rest of LATAM

    8.5.9.1. Overview

    8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.6. Middle East and Africa

    8.6.1. Overview

    8.6.2. Key Manufacturers in Middle East and Africa

    8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    8.6.4. Middle East and Africa Market Size and Forecast, By Types, 2015 - 2026 (US$ Million)

    8.6.5. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    8.6.6. Saudi Arabia

    8.6.6.1. Overview

    8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.6.7. United Arab Emirates

    8.6.7.1. Overview

    8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Abbott Laboratories

    9.1.1. Company Snapshot

    9.1.2. Financial Performance

    9.1.3. Product Benchmarking

    9.1.4. Strategic Initiatives

    9.2. Catalent, Inc.

    9.3. Thermo Fisher Scientific Inc.

    9.4. GE Healthcare

    9.5. Eurofins Scientific

    9.6. Quest Diagnostics Incorporated

    9.7. Evotec

    9.8. Merck KGaA

    9.9. Bio-Rad Laboratories, Inc.

    9.10. Charles River

    9.11. Laboratory Corporation of America Holdings

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. References

    11.3. Abbreviations

    11.4. Disclaimer

    11.5. Contact Us

List Of Tables
in Irritable Bowel Syndrome (IBS) Treatment Market, By Type (Viberzi, Amitiza, Xifaxan, Linzess/Constella), By Product, and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Irritable Bowel Syndrome (IBS) Treatment market: Types Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Types

TABLE Global Irritable Bowel Syndrome (IBS) Treatment market, by Types 2015-2026 (USD Million)

TABLE Irritable Bowel Syndrome (IBS) Treatment market: Product Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Product

TABLE Global Irritable Bowel Syndrome (IBS) Treatment market, by Product 2015-2026 (USD Million)

TABLE Irritable Bowel Syndrome (IBS) Treatment market: Regional snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Irritable Bowel Syndrome (IBS) Treatment market, by Region 2015-2026 (USD Million)

TABLE North America Irritable Bowel Syndrome (IBS) Treatment market, by Country, 2015-2026 (USD Million)

TABLE North America Irritable Bowel Syndrome (IBS) Treatment market, by Types, 2015-2026 (USD Million)

TABLE North America Irritable Bowel Syndrome (IBS) Treatment market, by Product, 2015-2026 (USD Million)

TABLE Europe Irritable Bowel Syndrome (IBS) Treatment market, by country, 2015-2026 (USD Million)

TABLE Europe Irritable Bowel Syndrome (IBS) Treatment market, by Types, 2015-2026 (USD Million)

TABLE Europe Irritable Bowel Syndrome (IBS) Treatment market, by Product, 2015-2026 (USD Million)

TABLE Asia Pacific Irritable Bowel Syndrome (IBS) Treatment market, by country, 2015-2026 (USD Million)

TABLE Asia Pacific Irritable Bowel Syndrome (IBS) Treatment market, by Types, 2015-2026 (USD Million)

TABLE Asia Pacific Irritable Bowel Syndrome (IBS) Treatment market, by Product, 2015-2026 (USD Million)

TABLE Latin America Irritable Bowel Syndrome (IBS) Treatment market, by country, 2015-2026 (USD Million)

TABLE Latin America Irritable Bowel Syndrome (IBS) Treatment market, by Types, 2015-2026 (USD Million)

TABLE Latin America Irritable Bowel Syndrome (IBS) Treatment market, by Product, 2015-2026 (USD Million)

TABLE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market, by country, 2015-2026 (USD Million)

TABLE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market, by Types, 2015-2026 (USD Million)

TABLE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market, by Product, 2015-2026 (USD Million)

List Of Figures, Charts and Diagrams
in Irritable Bowel Syndrome (IBS) Treatment Market, By Type (Viberzi, Amitiza, Xifaxan, Linzess/Constella), By Product, and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Figures

FIGURE Irritable Bowel Syndrome (IBS) Treatment market segmentation

FIGURE Market research Typesology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparision Study

FIGURE Competitive Landscape; Key company market share analysis, 2018

FIGURE Types segment market share analysis, 2019 & 2026

FIGURE Types segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE IBS-D segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Viberzi segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Xifaxan segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE IBS-C segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Amitiza segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Linzess/Constella segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Product segment market share analysis, 2019 & 2026

FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2026

FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE North America Irritable Bowel Syndrome (IBS) Treatment market share and leading players, 2018

FIGURE Europe Irritable Bowel Syndrome (IBS) Treatment market share and leading players, 2018

FIGURE Asia Pacific Irritable Bowel Syndrome (IBS) Treatment market share and leading players, 2018

FIGURE Latin America Irritable Bowel Syndrome (IBS) Treatment market share and leading players, 2018

FIGURE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market share and leading players, 2018

FIGURE North America Irritable Bowel Syndrome (IBS) Treatment market share analysis by country, 2018

FIGURE U.S. Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Canada Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Europe Irritable Bowel Syndrome (IBS) Treatment market share analysis by country, 2018

FIGURE Germany Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Spain Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Italy Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE UK Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE France Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of the Europe Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Asia Pacific Irritable Bowel Syndrome (IBS) Treatment market share analysis by country, 2018

FIGURE India Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE China Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Japan Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE South Korea Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Singapore Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of APAC Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Irritable Bowel Syndrome (IBS) Treatment market share analysis by country, 2018

FIGURE Brazil Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Mexico Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Argentina Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of LATAM Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment market share analysis by country, 2018

FIGURE Saudi Arabia Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE United Arab Emirates Irritable Bowel Syndrome (IBS) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270620 | AV82

Number of Pages

170

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Irritable Bowel Syndrome-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Irritable Bowel Syndrome -...
30 May 2017 by Delve Insight USD $4,950 More Info
Irritable Bowel Syndrome - Pipeline Review, H1 2017
Irritable Bowel Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceuti...
23 May 2017 by Global Markets Direct USD $2,000 More Info
Global Irritable Bowel Syndrome Partnering 2010-2017
The Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2010 report provides under...
01 Apr 2017 by Current Partnering USD $1,495 More Info
Global Irritable Bowel Syndrome Partnering 2010-2017
The Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2010 report provides under...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 M...
01 Feb 2017 by Black Swan Analysis USD $6,100 More Info
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial r...
30 Nov 2016 by Global Data USD $2,500 More Info
Global Irritable Bowel Syndrome Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Irritable Bowel Syndrome Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial r...
16 Dec 2015 by Global Data USD $2,500 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Irritable Bowel Syndrome (IBS) Treatment Market, By Type (Viberzi, Amitiza, Xifaxan, Linzess/Constella), By Product, and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...